Benzinga's Top Initiations
Analysts at Guggenheim Securities initiated coverage on Five Prime Therapeutics Inc (NASDAQ: FPRX) with a Buy rating. The target price for Five Prime Therapeutics is set to $31. Five Prime Therapeutics' shares closed at $21.01 yesterday.
Analysts at Guggenheim Securities initiated coverage on Merrimack Pharmaceuticals Inc (NASDAQ: MACK) with a Buy rating. The target price for Merrimack Pharmaceuticals is set to $15. Merrimack Pharmaceuticals' shares closed at $11.52 yesterday.
Analysts at Pacific Crest initiated coverage on Mobileye NV (NYSE: MBLY) with a Sector Weight rating. Mobileye shares closed at $46.23 yesterday.
Evercore Partners initiated coverage on Criteo SA (ADR) (NASDAQ: CRTO) with a Hold rating. The target price for Criteo is set to $45. Criteo shares closed at $44.89 yesterday.
Analysts at Oppenheimer initiated coverage on Horizon Technology Finance Corp (NASDAQ: HRZN) with a Outperform rating. The target price for Horizon Technology is set to $15. Horizon Technology shares closed at $14.16 yesterday.
Gabelli initiated coverage on A O Smith Corp (NYSE: AOS) with a Hold rating. A O Smith shares closed at $68.22 yesterday.
Analysts at Canaccord Genuity initiated coverage on Royal Gold, Inc (USA) (NASDAQ: RGLD) with a Hold rating. The target price for Royal Gold is set to $72.50. Royal Gold shares closed at $66.19 yesterday.
Stifel Nicolaus initiated coverage on US Concrete Inc (NASDAQ: USCR) with a Buy rating. The target price for US Concrete is set to $45. US Concrete shares closed at $37.60 yesterday.
Analysts at Oppenheimer initiated coverage on Monroe Capital Corp (NASDAQ: MRCC) with a Outperform rating. The target price for Monroe Capital is set to $15. Monroe Capital shares closed at $14.62 yesterday.
Canaccord Genuity initiated coverage on Silver Wheaton Corp. (USA) (NYSE: SLW) with a Buy rating. Silver Wheaton shares closed at $20.14 yesterday.
Latest Ratings for FPRX
Date | Firm | Action | From | To |
---|---|---|---|---|
Mar 2021 | Guggenheim | Downgrades | Buy | Neutral |
Mar 2021 | Jefferies | Downgrades | Buy | Hold |
Nov 2020 | SVB Leerink | Reiterates | Outperform |
View More Analyst Ratings for FPRX
View the Latest Analyst Ratings
© 2021 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Posted-In: Top InitiationsInitiation Analyst Ratings